A prospective multicentre observational study on the management of patients on oral anticoagulation undergoing coronary artery stenting: Rationale and design of the ongoing warfarin and coronary stenting (WAR-STENT) registry

Journal of Cardiovascular Medicine

Volumn 10, Issue 2, 2009, Pages 200-203

  Rubboli, Andrea ^a   Bolognese, Leonardo ^b   Di Pasquale, Giuseppe ^a   Galvani, Marcello ^c   La Vecchia, Luigi ^d   Maggioni, Aldo P ^e  

^a MAGGIORE HOSPITAL   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c MORGAGNI PIERANTONI HOSPITAL   (Italy)

^d SAN BORTOLO HOSPITAL   (Italy)

^e ANMCO RESEARCH CENTER   (Italy)

Author keywords

Antiplatelet agents; Oral anticoagulation; Percutaneous coronary intervention; Stent

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; WARFARIN; ANTICOAGULANT AGENT;

AMBULATORY CARE; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CAUSE OF DEATH; CLINICAL TRIAL; CORONARY STENT; DEATH; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HEART DEATH; HEART DISEASE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; ITALY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; STENT THROMBOSIS; TREATMENT OUTCOME; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; CORONARY ARTERY DISEASE; INSTRUMENTATION; METHODOLOGY; ORAL DRUG ADMINISTRATION; REGISTER; RISK ASSESSMENT; STENT; THROMBOEMBOLISM; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADMINISTRATION, ORAL; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; CORONARY ARTERY DISEASE; HEMORRHAGE; HUMANS; ITALY; PROSPECTIVE STUDIES; REGISTRIES; RESEARCH DESIGN; RISK ASSESSMENT; STENTS; THROMBOEMBOLISM; THROMBOSIS; WARFARIN;

EID: 65549101104     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e3283212f07     Document Type: Article

References (23)

1. The ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet 2006; 367:1903-1912.
2. Schlitt A, von Bardeleben RS, Ehrlich A, Eimermacher A, Peetz D, Dahm M, et al. Clopidogrel and aspirin in the prevention of thromboembolic complications after mechanical aortic valve replacement (CAPTA). Thromb Res 2003; 109:131-135. (Pubitemid 36428764)
3. Rubboli A, Milandri M, Castelvetri C, Cosmi B. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with indication for long-term anticoagulation undergoing coronary stenting. Cardiology 2005; 104:101-106.
4. Mattichak SJ, Reed PS, Gallagher MJ, Boura JA, O'Neill WW, Kahn JK. Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol 2005; 18:163-166. (Pubitemid 40942726)
5. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, et al. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006; 18:162-164. (Pubitemid 44576090)
6. Konstantino Y, Iakobishvili Z, Porter A, Sandach A, Zagher D, Hod H, et al. Aspirin, warfarin and a thienopyridine for acute coronary syndromes. Cardiology 2006; 106:80-85. (Pubitemid 43189779)
7. DeEugenio D, Kolman L, DeCaro M, Andrel J, Chervoneva I, Duong P, et al. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacoherapy 2007; 27:691-696. (Pubitemid 46700961)
8. Rubboli A, Colletta M, Herzfeld J, Sangiorgio P, Di Pasquale G. Periprocedural and medium-term antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary angiography and intervention. Coron Artery Dis 2007; 18:193-199. (Pubitemid 46608497)
9. Wang TY, Robinson LA, Ou F-S, Roe MT, Ohman EM, Gibler B, et al. Discharge antithrombotic strategies among patients with acute coronary syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry. Am Heart J 2008; 155:361-368.
10. Manzano-Fernandez S, Pastor FJ, Marin F, Cambronero F, Caro C, Pascual-Figal DA, et al. Increased major bleeding complications related to triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008; 134:559-567.
11. Rubboli A, Halperin JL, Airaksinen JK, Buerke M, Eeckhout E, Freedman SB, et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med 2008; 40:428-436.
12. Karjalainen PP, Porela P, Ylitalo A, Vikman S, Nyman K, Vaittinen MA, et al. Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting. Eur Heart J 2007; 28:726-732. (Pubitemid 46439228)
13. Sarafoff N, Ndrepepa G, Mehilli J, Dö rrler K, Schulz S, Iijima R, et al. Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med 2008; 264:472-480.
14. Nguyen MC, Lim YL, Walton A, Lefkovits J, Agnelli G, Goodman SG, et al. Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J 2007; 28:1717-1722.
15. Valencia J, Mainar V, Bordes P, Pineda J, Gomez S, Sogorb F. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment. J Interven Cardiol 2008; 21:218-224. (Pubitemid 351703983)
16. King SB 3rd, Smith SC, Hirshfeld JW Jr, Jacobs AK, Morrison DA, Williams DO, et al. 2007 Focus updated of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2007 Writing Group to review new evidence and update the 2005 ACC/AHA/SCAI guideline update for percutaneous coronary intervention). J Am Coll Cardiol 2008; 51:171-209.
17. Antman EM, Hand M, Armstrong PW, Bates ER, Green LA, Halasyamani LK, et al. 2007 Focus update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Group to review new evidence and update the ACC/AHA 2004 Guidelines for the Management of Acute Myocardial Infarction). Circulation 2008; 117:296-329.
18. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casedy DE Jr, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation 2007; 116:e148-e304.
19. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006; 48:854-906.
20. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease. The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230-268.
21. Thygesen K, Alpert JS, White HD, Joint ESC/ACCF/AHA/WHF Task Force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation 2007; 116:2634-2653.
22. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-2351. (Pubitemid 46685903)
23. Koertke H, Minami K, Boethig D, Breymann T, Seifert D, Wagner O, et al. INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 2003; 108 (Suppl 1):II75-II78. (Pubitemid 37099934)